LENZ 10 Year Annualized Return and Average Annual Return

LENZ Average Annual Return Chart Since 2021
Growth of $10,000.00
With Dividends Reinvested Into LENZ

Also see:
• LENZ stock yearly return 2021
• LENZ stock yearly return 2022
• LENZ stock yearly return 2023
• LENZ stock yearly return 2024
• LENZ stock yearly return 2025
• LENZ YTD return
Average Annual Return Benchmarks
Compare LENZ average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
LENZ Share Performance
LENZ Average Annual Return Table Since 2021
Start date: 06/25/2021
End date: 06/10/2026
Start price/share: $129.50
End price/share: $6.58
Starting shares: 77.22
Ending shares: 146.00
Dividends reinvested/share: $14.42
Total return: -90.39%
LENZ Average Annual Return: -37.63%
Starting investment: $10,000.00
Ending investment: $961.04


LENZ average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
About Lenz Therapeutics Inc New
LENZ Therapeutics, Inc. is a late clinical-stage biopharmaceutical company. Co. is focused on developing the first aceclidine-based eye drop to improve vision in patients diagnosed with presbyopia. Its product candidates, LNZ100 and LNZ101, are preservative-free, single-use, once-daily eye drops containing aceclidine and aceclidine plus brimonidine, respectively. LNZ100 and LNZ101 are under clinical evaluation in the registration-enabling Phase III CLARITY trials as potential therapies for the treatment of presbyopia, a condition impacting an estimated 1.8 billion people globally and 128 million people in the U.S.. The LENZ average annual return since 2021 is shown above.

The Average Annual Return on the LENZ average annual return since 2021 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether LENZ average annual return since 2021 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the LENZ average annual return calculation with any dividends reinvested as applicable (on ex-dates).
LENZ Current Stock Quote
Quotes delayed 20 minutes

Email EnvelopeFree LENZ Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Featured Slideshows
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!
Video: Don't Forget Dividends in Average Annual Return!
Average Annual Return Peers
Lenz Therapeutics (LENZ) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

LEXX Average Annual Return
LFMD Average Annual Return
LFST Average Annual Return
LGMK Average Annual Return
LGND Average Annual Return
LGVN Average Annual Return
LH Average Annual Return
LIFE Average Annual Return
LIPO Average Annual Return
LITS Average Annual Return
More Healthcare companies »
 

LENZ 10 Year Annualized Return & Average Annual Return | www.AverageAnnualReturn.com | Copyright © 2021 - 2026, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.